Literature DB >> 35941326

Exosomal microRNA-551b-3p from bone marrow-derived mesenchymal stromal cells inhibits breast cancer progression via regulating TRIM31/Akt signaling.

Ziang Yang1, Bei Xu2, Sheng Wu3, Weige Yang1, Rongkui Luo4, Shengkai Geng5, Zhaochen Xin1, Wen Jin2, Xiong Shen6, Xixi Gu7, Hongwei Zhang1, Hong Wang8.   

Abstract

Mesenchymal stromal cells (MSCs) play an important role in the development of human cancer. Meanwhile, exosomes released by MSCs can mediate cell-cell communication by delivering microRNAs (miRNAs/miRs). Hence, this study aimed to explore the role of bone marrow mesenchymal stromal cell (BMSC)-derived exosomal miR-551b-3p in breast cancer. In this study, we found that upregulation of miR-551b-5p suppressed the proliferation and migration and induced the apoptosis of breast cancer cells via downregulating tripartite motif-containing protein 31 (TRIM31). In addition, miR-551b-5p could be transferred from BMSCs to breast cancer cells via exosomes; BMSC-derived exosomal miR-551b-3p suppressed the proliferation and migration and promoted the apoptosis and oxidative stress of MDA-MB-231 cells via inhibiting TRIM31. Furthermore, a xenograft mouse model was used to explore the role of BMSC-derived exosomal miR-551b-3p in vivo. We found that BMSC-derived exosomal miR-551b-3p inhibited tumor growth in a mouse xenograft model of breast cancer in vivo. Collectively, these findings indicated that BMSC-derived exosomal miR-551b-3p could suppress the development of breast cancer via downregulating TRIM31. Thus, miR-551b-3p could serve as a potential target for the treatment of breast cancer.
© 2022. The Author(s) under exclusive licence to Japan Human Cell Society.

Entities:  

Keywords:  Bone marrow mesenchymal stromal cells; Breast cancer; Exosome; Proliferation; microRNAs

Mesh:

Substances:

Year:  2022        PMID: 35941326     DOI: 10.1007/s13577-022-00753-x

Source DB:  PubMed          Journal:  Hum Cell        ISSN: 0914-7470            Impact factor:   4.374


  40 in total

1.  Mesenchymal stem versus stromal cells: International Society for Cell & Gene Therapy (ISCT®) Mesenchymal Stromal Cell committee position statement on nomenclature.

Authors:  S Viswanathan; Y Shi; J Galipeau; M Krampera; K Leblanc; I Martin; J Nolta; D G Phinney; L Sensebe
Journal:  Cytotherapy       Date:  2019-09-13       Impact factor: 5.414

2.  Histological Grade and Immunohistochemical Biomarkers of Breast Cancer: Correlation to Ultrasound Features.

Authors:  Frederick Wing-Fai Au; Sandeep Ghai; Fang-I Lu; Hadas Moshonov; Pavel Crystal
Journal:  J Ultrasound Med       Date:  2017-05-27       Impact factor: 2.153

3.  Breast cancer screening compliance among young women in a free access healthcare system.

Authors:  Asna Amin; Craig D Shriver; Leonard R Henry; Sarah Lenington; George E Peoples; Alexander Stojadinovic
Journal:  J Surg Oncol       Date:  2008-01-01       Impact factor: 3.454

4.  Human MSCs promotes colorectal cancer epithelial-mesenchymal transition and progression via CCL5/β-catenin/Slug pathway.

Authors:  Ke Chen; Qianqian Liu; Lai Ling Tsang; Qiao Ye; Hsiao Chang Chan; Yunwei Sun; Xiaohua Jiang
Journal:  Cell Death Dis       Date:  2017-05-25       Impact factor: 8.469

5.  The prognostic roles of mRNAs of the exosomes derived from bone marrow stromal cells in common malignancies: a bioinformatic study.

Authors:  Fei Zhao; Yan-Qiu Yu
Journal:  Onco Targets Ther       Date:  2018-11-12       Impact factor: 4.147

6.  Hypoxic BMSC-derived exosomal miRNAs promote metastasis of lung cancer cells via STAT3-induced EMT.

Authors:  Xina Zhang; Buqing Sai; Fan Wang; Lujuan Wang; Yuhui Wang; Leliang Zheng; Guiyuan Li; Jingqun Tang; Juanjuan Xiang
Journal:  Mol Cancer       Date:  2019-03-13       Impact factor: 27.401

Review 7.  Roles of Lysyl Oxidase Family Members in the Tumor Microenvironment and Progression of Liver Cancer.

Authors:  Hung-Yu Lin; Chia-Jung Li; Ya-Ling Yang; Ying-Hsien Huang; Ya-Tze Hsiau; Pei-Yi Chu
Journal:  Int J Mol Sci       Date:  2020-12-21       Impact factor: 5.923

8.  Effects of rat bone marrow-derived mesenchymal stem cells on breast cancer cells with differing hormone receptor status.

Authors:  Ying Wang; Shan Shao; Minna Luo; Shangke Huang; Lu Feng; Na Yuan; Fang Wu; Chengxue Dang; Xinhan Zhao
Journal:  Oncol Lett       Date:  2017-10-03       Impact factor: 2.967

9.  MSCs inhibit tumor progression and enhance radiosensitivity of breast cancer cells by down-regulating Stat3 signaling pathway.

Authors:  Ningning He; Yangyang Kong; Xudan Lei; Yang Liu; Jinhan Wang; Chang Xu; Yan Wang; Liqing Du; Kaihua Ji; Qin Wang; Zongjin Li; Qiang Liu
Journal:  Cell Death Dis       Date:  2018-10-08       Impact factor: 8.469

10.  The Clinicopathological features and survival outcomes of patients with different metastatic sites in stage IV breast cancer.

Authors:  Ru Wang; Yayun Zhu; Xiaoxu Liu; Xiaoqin Liao; Jianjun He; Ligang Niu
Journal:  BMC Cancer       Date:  2019-11-12       Impact factor: 4.430

View more
  1 in total

Review 1.  Natural products exert anti-tumor effects by regulating exosomal ncRNA.

Authors:  Shuang Hu; Yi Liu; Shuguang Guan; Zhidong Qiu; Da Liu
Journal:  Front Oncol       Date:  2022-09-20       Impact factor: 5.738

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.